首页> 外文期刊>Clinical cardiology. >Inspiratory Muscle Training and Functional Electrical Stimulation for Treatment of Heart Failure With Preserved Ejection Fraction: Rationale and Study Design of a Prospective Randomized Controlled Trial
【24h】

Inspiratory Muscle Training and Functional Electrical Stimulation for Treatment of Heart Failure With Preserved Ejection Fraction: Rationale and Study Design of a Prospective Randomized Controlled Trial

机译:吸气肌训练和功能电刺激治疗心力衰竭伴射血分数不变:前瞻性随机对照试验的原理和研究设计

获取原文
获取外文期刊封面目录资料

摘要

Abstract Heart failure with preserved ejection fraction (HFpEF) has become the most prevalent form of heart failure in developed countries. Regrettably, there is no evidence-based effective therapy for HFpEF. We seek to evaluate whether inspiratory muscle training, functional electrical stimulation, or a combination of both can improve exercise capacity as well as left ventricular diastolic function, biomarker profile, quality of life (QoL), and prognosis in patients with HFpEF. A total of 60 stable symptomatic patients with HFpEF (New York Heart Association class II–III/IV) will be randomized (1:1:1:1) to receive a 12-week program of inspiratory muscle training, functional electrical stimulation, a combination of both, or standard care alone. The primary endpoint of the study is change in peak exercise oxygen uptake; secondary endpoints are changes in QoL, echocardiogram parameters, and prognostic biomarkers. As of March 21, 2016, thirty patients have been enrolled. Searching for novel therapies that improve QoL and autonomy in the elderly with HFpEF has become a health care priority. We believe that this study will add important knowledge about the potential utility of 2 simple and feasible physical interventions for the treatment of advanced HFpEF.
机译:摘要保留射血分数(HFpEF)的心力衰竭已成为发达国家中最普遍的心力衰竭形式。遗憾的是,目前尚无基于证据的HFpEF有效疗法。我们试图评估吸气肌肉训练,功能性电刺激或两者结合可以改善HFpEF患者的运动能力以及左心室舒张功能,生物标志物谱,生活质量(QoL)和预后。共有60名稳定的HFpEF症状患者(纽约心脏协会II–III / IV级)将被随机分配(1:1:1:1),接受为期12周的吸气肌肉训练,功能性电刺激,两者结合使用,或单独使用标准护理。该研究的主要终点是峰值运动氧摄入量的变化。次要终点是QoL,超声心动图参数和预后生物标志物的变化。截至2016年3月21日,已有30名患者入组。在HFpEF中寻找能够改善老年人的QoL和自主性的新疗法已成为医疗保健的重点。我们相信,这项研究将增加有关2种简单可行的物理干预措施治疗晚期HFpEF的潜在效用的重要知识。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号